Tokuyama S[au] - Search Results

Year	Number of Results
1987	1
1988	1
1989	2
1990	1
1991	3
1992	5
1993	2
1994	4
1995	7
1996	13
1997	7
1998	7
1999	8
2000	6
2001	8
2002	10
2003	1
2004	1
2005	1
2006	1
2007	7
2008	4
2009	10
2010	11
2011	27
2012	24
2013	21
2014	23
2015	19
2016	18
2017	11
2018	12
2019	7
2020	5
2021	4
2022	2

1

Shogo Tokuyama.

Tokuyama S. Tokuyama S. Med Cannabis Cannabinoids. 2018 Jun 12;1(1):8. doi: 10.1159/000489139. eCollection 2018 Jun. Med Cannabis Cannabinoids. 2018. PMID: 34676316 Free PMC article. No abstract available.

2

Retraction Note to: Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Harada S, Kishimoto M, Kobayashi M, Nakamoto K, Fujita-Hamabe W, Chen HH, Chan MH, Tokuyama S. Harada S, et al. Among authors: tokuyama s. J Nat Med. 2020 Jun;74(3):618. doi: 10.1007/s11418-020-01392-y. J Nat Med. 2020. PMID: 32125623

3

Retraction notice to "The importance of regulation of blood glucose levels through activation of peripheral 5'-AMP-activated protein kinase on ischemic neuronal damage" [Brain Res 1351 (2010) 254-263].

Harada S, Fujita-Hamabe W, Tokuyama S. Harada S, et al. Among authors: tokuyama s. Brain Res. 2021 May 1;1758:147363. doi: 10.1016/j.brainres.2021.147363. Epub 2021 Feb 17. Brain Res. 2021. PMID: 33610264 No abstract available.

4

Retraction notice to "Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activation" [Brain Res. 1661 (2017) 100-110].

Harada S, Nozaki Y, Matsuura W, Yamazaki Y, Tokuyama S. Harada S, et al. Among authors: tokuyama s. Brain Res. 2021 May 1;1758:147364. doi: 10.1016/j.brainres.2021.147364. Epub 2021 Feb 17. Brain Res. 2021. PMID: 33610263 No abstract available.

5

Retraction notice to "Possible involvement of the HMGB1/RAGE signaling mechanism in the induction of central post-stroke pain induced by acute global cerebral ischemia" [Brain Res. J. Volume 1646, 1 September 2016, Pages 433-440].

Harada S, Matsuura W, Liu K, Nishibori M, Tokuyama S. Harada S, et al. Among authors: tokuyama s. Brain Res. 2021 Apr 1;1756:147340. doi: 10.1016/j.brainres.2021.147340. Epub 2021 Feb 5. Brain Res. 2021. PMID: 33558050 No abstract available.

6

RETRACTED: Effect of Orexin-A on Post-ischemic Glucose Intolerance and Neuronal Damage.

Harada S, Fujita-Hamabe W, Tokuyama S. Harada S, et al. Among authors: tokuyama s. J Pharmacol Sci. 2011;115(2):155-163. doi: 10.1254/jphs.10264FP. Epub 2019 Jun 11. J Pharmacol Sci. 2011. PMID: 32272533 Free article.

7

RETRACTED: Ameliorating Effect of Hypothalamic Brain-Derived Neurotrophic Factor Against Impaired Glucose Metabolism After Cerebral Ischemic Stress in Mice.

Harada S, Fujita-Hamabe W, Tokuyama S. Harada S, et al. Among authors: tokuyama s. J Pharmacol Sci. 2012;118(1):109-116. doi: 10.1254/jphs.11164FP. Epub 2019 Jun 11. J Pharmacol Sci. 2012. PMID: 32092832 Free article.

8

Sodium-glucose transporter as a novel therapeutic target in disease.

Yamazaki Y, Harada S, Tokuyama S. Yamazaki Y, et al. Among authors: tokuyama s. Eur J Pharmacol. 2018 Mar 5;822:25-31. doi: 10.1016/j.ejphar.2018.01.003. Epub 2018 Jan 9. Eur J Pharmacol. 2018. PMID: 29329760 Review.

9

Unsaturated fatty acids and pain.

Tokuyama S, Nakamoto K. Tokuyama S, et al. Biol Pharm Bull. 2011;34(8):1174-8. doi: 10.1248/bpb.34.1174. Biol Pharm Bull. 2011. PMID: 21804202 Free article. Review.

10

[Elucidation of mechanisms underlying docosahexaenoic acid-induced antinociception].

Nishinaka T, Matsumoto K, Nakamoto K, Anbo A, Mankura M, Koyama Y, Tokuyama S. Nishinaka T, et al. Among authors: tokuyama s. Yakugaku Zasshi. 2013;133(5):493-9. doi: 10.1248/yakushi.12-00278-2. Yakugaku Zasshi. 2013. PMID: 23649389 Free article. Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results